• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 11
  3. Author

Online ISSN: 2515-8260

Volume7, Issue11

Formulation and In-Vitro Evaluation of Matrix Type Transdermal Patches of Glibenclamide Using Various Penetration Enhancers

    Fatin Nabila Md Ami , Mohammed Kaleemullah , Jiyauddin Khan, Samer Al-Dhalli , Sakina Ruhi , Mohamed Rasny , Shariq Baber , Santosh Fattepur , Kiran Nilugal, Chean Hui Ng, Gamal O. E , Ibrahim Abdullah

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 11, Pages 518-525

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background and aim: Transdermal medication conveyance is one of the sort of organization which has been catching eye over the previous years concerning its potential in ailment treatment. The utilized of entrance enhancers which may improve the bioavailability and broaden the scope of medications are concentrated in the organization of transdermal course. Its utilization in this field might be helpful in reversibly lessen the hindrance capacity of the layer corneum, the furthest layer of the skin. For this analysis, the definition and assessment of transdermal patches of Glibenclamide towards improving saturation through the skin and keeping up the plasma focus utilizing different infiltration enhancers have been researched. Materials and methods: The transdermal were set up by the dissolvable throwing strategy utilizing HPMC and PVA as the polymers notwithstanding the dibutylphthalate as a plasticizer. The infiltration enhancers utilized are oleic corrosive, DMSO, D-limonene, and Sodium Lauryl Sulfate. The transdermal patches have been assessed by their physicochemical properties and in-vitro drug release. Results: The transdermal patches appearance were straightforward and smooth surface, no huge varieties of thickness, weight varieties and collapsing perseverance. Among the definitions considered, F4 which has D-limonene as infiltration enhancers demonstrated great attributes with low dampness misfortune and dampness take-up, most extreme medication arrival of 99.713% and medication content with 92.588% ± 0.8541. Conclusion: The current examinations demonstrated the necessary penetration pace of the medications might be accomplished with the guide of enhancers either physical or substance.
Keywords:
  • PDF (187 K)
  • XML
(2020). Formulation and In-Vitro Evaluation of Matrix Type Transdermal Patches of Glibenclamide Using Various Penetration Enhancers. European Journal of Molecular & Clinical Medicine, 7(11), 518-525.
Fatin Nabila Md Ami , Mohammed Kaleemullah , Jiyauddin Khan, Samer Al-Dhalli , Sakina Ruhi , Mohamed Rasny , Shariq Baber , Santosh Fattepur , Kiran Nilugal, Chean Hui Ng, Gamal O. E , Ibrahim Abdullah. "Formulation and In-Vitro Evaluation of Matrix Type Transdermal Patches of Glibenclamide Using Various Penetration Enhancers". European Journal of Molecular & Clinical Medicine, 7, 11, 2020, 518-525.
(2020). 'Formulation and In-Vitro Evaluation of Matrix Type Transdermal Patches of Glibenclamide Using Various Penetration Enhancers', European Journal of Molecular & Clinical Medicine, 7(11), pp. 518-525.
Formulation and In-Vitro Evaluation of Matrix Type Transdermal Patches of Glibenclamide Using Various Penetration Enhancers. European Journal of Molecular & Clinical Medicine, 2020; 7(11): 518-525.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 192
  • PDF Download: 459
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus